Every recall we track for Amgen, Inc. — 12 in all — plus the complaints and injury reports the public filed about them.
Amgen recalls 30mg Sensipar tablets with CGMP deviations. This prescription medication may have quality issues affecting safety. Consumers should contact Amgen for details.
Amgen recalls 90mg Sensipar tablets with CGMP deviations; affected lots may pose quality risks. Consumers should check NDC and expiration dates for affected products.
Amgen recalls 60mg Sensipar tablets with CGMP deviations. This prescription medication may have quality issues affecting safety. Consumers should contact Amgen for details.
Amgen recalls Corlanor 5mg tablets (NDC 55513-800-99 and 55513-800-60) due to foreign substance presence. Rx-only medication with specific lot numbers and expiration dates.
Amgen recalls 7.5mg Corlanor tablets with foreign substance. Affected lots expire through 2028. No remedy specified in recall notice.
Amgen recalls Neupogen injections due to potential stability problems that could cause the product to be out of specification by its 36-month expiry date.
Amgen recalls Neupogen (filgrastim) vials that may lose potency before their 36-month expiry date. This could affect medication effectiveness if used after the stability period ends.
Amgen recalls MVASI (bevaciz:awwb) injections due to potential container leaks. This risk affects patients receiving the drug for cancer treatment. Contact Amgen for details.